Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT04677114
PHASE2

Integrated Outpatient Treatment of Opioid Use Disorder and Severe Injection Related Infections

Sponsor: Laura Fanucchi

View on ClinicalTrials.gov

Summary

This study will assess the efficacy of an integrated outpatient treatment model for persons with opioid use disorder and injection related infections. The investigators hypothesize that outpatient antibiotic treatment coupled with comprehensive treatment for opioid use disorder will demonstrate a safe and effective way to manage patients. Results could improve the current protocols for the treatment of individuals with opioid use disorder and severe infections.

Key Details

Gender

All

Age Range

18 Years - 99 Years

Study Type

INTERVENTIONAL

Enrollment

71

Start Date

2021-03-16

Completion Date

2025-03-06

Last Updated

2026-04-28

Healthy Volunteers

No

Interventions

DRUG

Buprenorphine and Outpatient Parenteral Antibiotic Therapy

Participants will be complete IV antibiotics with OPAT. All participants will receive buprenorphine treatment of OUD.

DRUG

Buprenorphine and standard of care antibiotic treatment

All participants will receive treatment of OUD and the infection per usual clinical care.

Locations (1)

University of Kentucky

Lexington, Kentucky, United States